DMAC
DiaMedica Therapeutics Inc. · Healthcare
Director Randall Michael Giuffre bought $45K of DiaMedica Therapeutics Inc.
Bought$45,000
$4.00Price
11,250Shares
+7%Stake
What DMAC did for a copier
Prices for DMAC after this filing aren't in yet.
Randall Michael Giuffre's record
4 other buys with 3 months of prices since 2020: on average +12.7% against the S&P 500, and 3 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Dec 11. Filed Tue, Dec 11, 11:17 AM ET, during the session. Not investment advice.